Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy

Abstract

Purpose: The aim of our study is to evaluate the undergrading and understaging rates in patients with clinically localized insignificant prostate cancer who underwent radical prostatectomy. Materials and Methods: Between July 2005 and July 2008, 406 patients underwent radical prostatectomy for clinical localized prostate cancer in our hospital. Based on preoperative data, 93 of these patients fulfilled our criteria of non-significance: Gleason score < 7, stage T1c, PSA < 10 ng/mL and percentage of affected fragments less than 25%. The pathologic stage and Gleason score were compared to preoperative data to evaluate the rate of understaging and undergrading. The biochemical recurrence free survival of these operated insignificant cancers were also evaluated. Results: On surgical specimen analysis 74.7% of patients had Gleason score of 6 or less and 25.3% had Gleason 7 or greater. Furthermore 8.3% of cases showed extracapsular extension. After 36 months of follow-up 3.4% had biochemical recurrence, defined by a PSA above 0.4 ng/mL. Conclusions: Despite the limited number of cases, we have found considerable rates of undergrading and understaging in patients with prostate cancer whose current definitions classified them as candidates for active surveillance. According to our results the current definition seems inadequate as up to a third of patients had higher grade or cancer outside the prostate.

The cost-utility of open prostatectomy compared with active surveillance in early localised prostate cancer

“…wrongly diagnosing an aggressive tumour as low risk, due to the limited predictive power of current diagnostic tools is a challenge for current urological research [54]. It has been shown that more than 25% of tumours may be wrongly diagnosed as insignificant in clinical practice [55,56]. Better diagnostic methods for identifying particularly aggressive tumours, e.g.…”

Laparoscopic Radical Prostatectomy Plus Extended Lymph Node Dissection in Combination With Immediate Androgen Deprivation Therapy for Cases of pT3-4N0-1M0 Prostate Cancer: A Multimodal Study of 8 Years' Follow-up

“…In China, prostate-specific antigen (PSA)screening has not been widely carried out. Of all initially diagnosedPCa, nearly 80 % is locallyadvanced or metastatic [6].Moreover, there were part of the preoperativediagnosed organ-confined PCa by imaging and biopsy whose postoperatively (RP or LRP) pathological TNM indicated a local advanced stage or positive lymph node [7]. Thus,toevaluate the value of LRP in treating locallyadvanced or lymph nodemetastatic PCa isimportant.As a Chinese institute,LRPhasbecome a routine treatment modality which we use to treat localized PCa [8].…”

Diagnostic Performance of Multiparametric Magnetic Resonance Imaging and Fusion Targeted Biopsy to Detect Significant Prostate Cancer

“…While PSA has a low sensitivity and specificity, DRE has a low PPV and a high inter-observer variability, resulting in overdiagnosing and overtreatment induced by false-positive findings. Similarly, studies have shown that TRUS-guided biopsy fails to detect cancer in about 20-30% of cases when present, and underdiagnoses the disease in about 25-40% of cases (2,3,(16)(17)(18).…”